About Us

NanoASIA Company Limited is a new private, local-investors-supported “bio-nanotech” business that focuses on developing and marketing biotechnology and nanotechnology products for Asia-Pacific countries. NanoAsia’s business objective is to apply new and innovative biobusiness solutions that focus on "the value chain of life sciences” to develop and sustain biomedical innovations in the Asia-Pacific region created by new and innovative technologies from Western biomedical markets.

NanoASIA was co-founded by Komkrit Sajjaanantakul (CEO) and William Porter, Jr. (President). Mr. Porter was former Senior Vice President of A-P Business Development for VDDI, USA, and Mr. Sajjaanantakul is one of the founders of i+MED Laboratories Co., Ltd., which is one of the leading bio-businesses in Thailand.

Nature of Business:

Our value-added solutions for Southeast Asia and South Asia life science businesses include:

Bioinformatics applications and solutions
Bioprocessing & Engineering
Next Generation Sequencing
Clinical Trial Management Services
Biochip-based biosensor technology
Clinical analyzers
Diagnostic reagents
Diagnostic Rapid Tests
Ceramic filter masks for viral and bacterial protection
Business and commercial development services in the Asia-Pacific biobusiness sector
Regulatory and resource mobilization services in the Asia-Pacific biobusiness sector
Marketing and distribution for nanobiotech products and services
Poultry vaccine made from live Salmonella Gallinarum 9R